News
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...
Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...
When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle ...
Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...
In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...
The pen finds early signs of Parkinson’s by studying handwriting. It works without batteries and can be used in regular check ...
6d
Clinical Trials Arena on MSNParkinson’s drug found to be effective in treating depressionDespite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.
Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...
A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results